Status:

RECRUITING

Intermittent Theta-burst Stimulation for Mild Cognitive Impairment

Lead Sponsor:

The Hong Kong Polytechnic University

Conditions:

Mild Cognitive Impairment (MCI)

Eligibility:

All Genders

65+ years

Phase:

NA

Brief Summary

The objectives of this study are to: 1. Evaluating the Impact of iTBS on Cognitive and Physical Functions: The investigators will investigate the efficacy of intermittent theta burst stimulation (iTB...

Detailed Description

Mild cognitive impairment (MCI) is a syndrome characterized by cognitive decline that is greater than expected with normal aging; however, it is not severe enough to meet dementia criteria. Accordingl...

Eligibility Criteria

Inclusion

  • Aged≥65 years;
  • Patient-reported subjective cognitive decline and the total score of the Hong Kong version of Montreal Cognitive Assessment (HK-MoCA) was between 19 and 25;
  • Intact daily functioning in ADL scales and being independent in daily living, and ability to walk at least for 1 minute independently without an assistive device;
  • No serious visual or hearing impairment and can complete relevant assessment and testing;
  • Signed informed consent of patients and their families for iTBS treatment.

Exclusion

  • Identified with contraindications in the rTMS screening questionnaire;
  • Cognitive dysfunction due to craniocerebral trauma or neurological diseases;
  • Presence of severe physical illnesses such as speech disorders or unstable cardiac arrhythmias;
  • Currently in a critical condition such as fever, infection, or organ failure;
  • Significant damage to the left frontal lobe cortex;
  • Currently taking antidepressants or psychostimulants;
  • Unstable vital signs or organ failure;
  • Neuropsychiatric comorbidity or affective disorder that could affect the test results;
  • Patients with dementia.

Key Trial Info

Start Date :

November 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 31 2027

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT06608316

Start Date

November 1 2024

End Date

October 31 2027

Last Update

March 13 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

The Hong Kong Polytechnic University

Hong Kong, Hong Kong, Hong Kong, 000000

2

The Hong Kong Polytechnic University

Hong Kong, Hong Kong, Hong Kong, 000000